cosopt preservative-free 20 mg/ml + 5 mg/ml eye drops, solution
santen oy - dorzolamide hydrochloride - eye drops, solution, single dose container - 22.26 mg - antiglaucoma preparations and miotics, beta blocking agents, timolol, combinations - indicated in the treatment of elevated intraocular pressure (iop) in patients with open-angle glaucoma or pseudoexfoliative glaucoma when topical beta-blocker monotherapy is not sufficient.
ikervis
santen oy - ciclosporin - corneal diseases - ophthalmologicals - treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes.
verkazia
santen oy - ciclosporin - conjunctivitis; keratitis - ophthalmologicals - treatment of severe vernal keratoconjunctivitis (vkc) in children from 4 years of age and adolescents.
rhokiinsa
santen oy - netarsudil - glaucoma, open-angle; ocular hypertension - ophthalmologicals - reduction of elevated intraocular pressure (iop) in adult patients with primary open-angle glaucoma or ocular hypertension.
timoptol 0.25% w/v eye drops, solution
santen oy - timolol base - eye drops, solution - 0.25 percent weight/volume - beta blocking agents1); timolol - it is a beta-adrenoreceptor blocking agent used topically in the reduction of elevated intra-ocular pressure in various conditions including the following: patients with ocular hypertension; patients with chronic open-angle glaucoma including aphakic patients; some patients with secondary glaucoma.
timoptol 0.5% w/v eye drops, solution
santen oy - timolol base - eye drops, solution - 0.5 percent weight/volume - beta blocking agents1); timolol - it is a beta-adrenoreceptor blocking agent used topically in the reduction of elevated intra-ocular pressure in various conditions including the following: patients with ocular hypertension; patients with chronic open-angle glaucoma including aphakic patients; some patients with secondary glaucoma.
trusopt 20 mg/ml eye drops, solution
santen oy - dorzolamide hydrochloride - eye drops, solution - 20 milligram(s)/millilitre - dorzolamide - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors, dorzolamide - it is indicated: as adjunctive therapy to beta-blockers, as monotherapy in patients unresponsive to beta-blockers or in whom beta-blockers are contraindicated, in the treatment of elevated intra-ocular pressure in: ocular hypertension, open-angle glaucoma, pseudoexfoliative glaucoma.
trusopt preservative-free 20 mg/ml eye drops, solution in single-dose container
santen oy - dorzolamide - eye drops, solution in single-dose container - 20 milligram(s)/millilitre - carbonic anhydrase inhibitors; dorzolamide - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors, dorzolamide - it l is indicated: as adjunctive therapy to beta-blockers; as monotherapy in patients unresponsive to beta-blockers or in whom beta-blockers are contraindicated; in the treatment of elevated intra-ocular pressure in: ocular hypertension; open-angle glaucoma; pseudoexfoliative glaucoma.
saflutan 15 micrograms/ml eye drops, solution, single-dose container
santen oy niittyhaankatu 20, 33720 tampere, finland - tafluprost - eye drops, solution - tafluprost 15 µg/ml - ophthalmologicals
saflutan 15 micrograms/ml, eye drops, solution in single-dose container
santen oy - tafluprost - eye drops, solution in single-dose container - 15 microgram(s)/millilitre - prostaglandin analogues1); tafluprost - antiglaucoma preparations and miotics, prostaglandin analogues - as monotherapy in patients: who would benefit from preservative free eye drops insufficiently responsive to first line therapy intolerant or contra-indicated to first line therapy. as adjunctive therapy to beta-blockers.